Worth reading
45Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
300000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数300,000Shares
Shares delivered during the month: 300,000 (both new shares and transferred treasury shares: "—" in the breakdown)
発行済株式総数
1.72% (exercise ratio subject to the exercise restriction), 1.75% (the number exercised during the month as a percentage of the total 170,982 rights issued)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price during the month was ¥69, ¥70 or ¥73. Details of the adjustment clause and the minimum price were not disclosed.
Number of Stock Acquisition Rights
Total issued: 170,982; exercised during the month: 3,000; unexercised at the end of the month preceding the reporting month: 167,369; unexercised at month-end: 164,369
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Announced on 16 April 2026: acquisition and cancellation of Series 3 stock acquisition rights; issuance of new shares through a third-party allotment; issuance of Series 1 unsecured convertible bonds with stock acquisition rights; issuance of Series 2 unsecured convertible bonds with stock acquisition rights (with a conversion price adjustment clause); and issuance and other matters concerning Series 4 stock acquisition rights (with an exercise price adjustment clause) (individual amounts not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered during the month: 300,000 (both new shares and transferred treasury shares: "—" in the breakdown) |
| Dilution Rate | 1.72% (exercise ratio subject to the exercise restriction), 1.75% (the number exercised during the month as a percentage of the total 170,982 rights issued) |
| Total number of issued shares | 18,822,705 shares (as of the end of the month preceding the reporting month) → Not disclosed |
| Exercise price | The exercise price during the month was ¥69, ¥70 or ¥73. Details of the adjustment clause and the minimum price were not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 170,982; exercised during the month: 3,000; unexercised at the end of the month preceding the reporting month: 167,369; unexercised at month-end: 164,369 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Announced on 16 April 2026: acquisition and cancellation of Series 3 stock acquisition rights; issuance of new shares through a third-party allotment; issuance of Series 1 unsecured convertible bonds with stock acquisition rights; issuance of Series 2 unsecured convertible bonds with stock acquisition rights (with a conversion price adjustment clause); and issuance and other matters concerning Series 4 stock acquisition rights (with an exercise price adjustment clause) (individual amounts not disclosed) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status. No other reason is stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.